Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-08-05

Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer [Phase 1]

View source ↗

Summary

Phase 1 cancer vaccine trial for metastatic or recurrent cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Breast Cancer, Gastric Cancer | Phase 1 | Status: WITHDRAWN